Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Overview
Lung Cancer: Journal of the International Association for the Study of Lung Cancer is a reputable scientific journal dedicated to advancing knowledge and understanding of lung cancer. It publishes cutting-edge research articles, reviews, and clinical studies, covering various aspects of lung cancer, including prevention, diagnosis, treatment, and supportive care. With a multidisciplinary approach, the journal serves as a valuable resource for researchers, clinicians, and healthcare professionals striving to improve outcomes for patients affected by this devastating disease.
Details
Details
Metrics
Metrics
h-index / Ranks: 1452
148
SJR / Ranks: 1480
1761
CiteScore / Ranks: 1344
10.30
JIF / Ranks: 1433
5.3
Recent Articles
1.
Uehara Y, Izumi H, Kobayashi I, Matsumoto S, Hosomi Y, Okuno T, et al.
Lung Cancer
. 2025 Mar;
202:108479.
PMID: 40088581
Background: EGFR exon 19 insertions (EGFRex19ins) are rare EGFR mutations. Their clinical-genomic characteristics and outcomes with EGFR-tyrosine kinase inhibitors (TKIs) remain uncertain. Methods: We evaluated the clinical-genomic characteristics and outcomes...
2.
Torasawa M, Yoshida T, Shiraishi K, Yagishita S, Ono H, Uehara Y, et al.
Lung Cancer
. 2025 Mar;
202:108494.
PMID: 40088580
Background: In EGFR-mutated lung adenocarcinoma (EGFRm LUAD), EGFR mutations do not necessarily result in increased EGFR expression (EGFR-exp), which differs among patients. However, the factors influencing EGFR-exp and the impact...
3.
Gridelli C, Attili I, Bennati C, Bironzo P, Bria E, Cortinovis D, et al.
Lung Cancer
. 2025 Mar;
202:108482.
PMID: 40086027
Background: Immune checkpoint inhibitors (ICIs) are currently included in the standard of care of the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC). However, a relevant group of clinically...
4.
Cho B, Johnson M, Bar J, Schaefer E, Yoh K, Zer A, et al.
Lung Cancer
. 2025 Mar;
202:108492.
PMID: 40086026
Background: Protein tyrosine kinase 7 (PTK7) overexpression in lung cancer is associated with tumor progression. Cofetuzumab pelidotin (Cofe-P) is an antibody-drug conjugate comprising an anti-PTK7 antibody conjugated to a microtubule...
5.
Gallina F, Marinelli D, Stiles B, Opitz I, Spicer J
Lung Cancer
. 2025 Mar;
202:108491.
PMID: 40081109
No abstract available.
6.
Laven I, Franssen A, Gronenschild M, Heineman D, Schreurs W, Hulsewe K, et al.
Lung Cancer
. 2025 Mar;
202:108481.
PMID: 40081108
Background And Objectives: Uniportal video-assisted thoracoscopic surgery (VATS) is an accepted surgical technique for lung cancer surgery worldwide. However, data on national patterns of uniportal VATS lung cancer resections are...
7.
Vinas F, Goussault H, Boyer L, Bussac G, Jabot L, Gibiot Q, et al.
Lung Cancer
. 2025 Mar;
202:108480.
PMID: 40058139
Introduction: Preoperative rehabilitation lowers the surgical morbidity-mortality risk of patients with non-small cell lung cancer (NSCLC). This study evaluated the feasibility of a preoperative-rehabilitation program consisting of high-intensity exercises, at...
8.
Frost M, Jensen K, Jimenez-Solem E, Qvortrup C, Andersen J, Petersen T
Lung Cancer
. 2025 Mar;
202:108485.
PMID: 40058138
Background: Historically, cancers often exhibit sexual dimorphism. However, following the introduction of immune checkpoint inhibitors and targeted therapies into routine clinical practice, the association of sex on patient and tumour...
9.
Iglesias Martinez B, Insa A, Cervera Ygual G, Gascon F, Dominguez Moran J, Martin-Martorell P
Lung Cancer
. 2025 Mar;
202:108464.
PMID: 40058137
Non-small cell lung cancer (NSCLC) constitutes 80-85% of lung cancer cases and is a leading cause of cancer-related mortality. Most patients are diagnosed at metastatic stages, where curative treatment is...
10.
Yang Y, Kim H, Park B, Lee J, Kim D, Lee C
Lung Cancer
. 2025 Mar;
202:108461.
PMID: 40056875
Objectives: To investigate the patterns and preoperative risk factors of occult lymph node metastasis (OLNM) in patients with stage I lung cancer. Methods: This retrospective study evaluated patients with clinical...